Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study

European EGPA Study Group; Giacomo Emmi

doi:10.1002/art.41943

Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study

European EGPA Study Group, Giacomo Emmi^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

7 Citations (Web of Science)

Original language	English
Pages (from-to)	295-306
Number of pages	12
Journal	Arthritis & Rheumatology
Volume	74
Issue number	2
Early online date	30 Dec 2021
DOIs	https://doi.org/10.1002/art.41943
Publication status	Published - Feb 2022

Keywords

FOLLOW-UP
PLACEBO
EGPA
SAFETY

Access to Document

10.1002/art.41943Licence: CC BY-NC-ND

Cite this

@article{1f21f273f84b4d65903a443ce00d9b7b,

title = "Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study",

keywords = "FOLLOW-UP, PLACEBO, EGPA, SAFETY",

author = "A. Bettiol and M.L. Urban and L. Dagna and V. Cottin and F. Franceschini and {Del Giacco}, S. and F. Schiavon and T. Neumann and G. Lopalco and P. Novikov and C. Baldini and C. Lombardi and A. Berti and F. Alberici and M. Folci and S. Negrini and R.A. Sinico and L. Quartuccio and C. Lunardi and P. Parronchi and F. Moosig and G. Espigol-Frigole and J. Schroeder and A.L. Kernder and S. Monti and E. Silvagni and C. Crimi and F. Cinetto and P. Fraticelli and D. Roccatello and A. Vacca and A.J. Mohammad and B. Hellmich and M. Samson and E. Bargagli and J.W.C. Tervaert and C. Ribi and D. Fiori and F. Bello and F. Fagni and L. Moroni and G.A. Ramirez and M. Nasser and C. Marvisi and P. Toniati and D. Firinu and R. Padoan and A. Egan and B. Seeliger and {European EGPA Study Group} and Giacomo Emmi",

year = "2022",

month = feb,

doi = "10.1002/art.41943",

language = "English",

volume = "74",

pages = "295--306",

journal = "Arthritis & Rheumatology",

issn = "2326-5191",

publisher = "Wiley",

number = "2",

}

TY - JOUR

T1 - Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study

AU - Bettiol, A.

AU - Urban, M.L.

AU - Dagna, L.

AU - Cottin, V.

AU - Franceschini, F.

AU - Del Giacco, S.

AU - Schiavon, F.

AU - Neumann, T.

AU - Lopalco, G.

AU - Novikov, P.

AU - Baldini, C.

AU - Lombardi, C.

AU - Berti, A.

AU - Alberici, F.

AU - Folci, M.

AU - Negrini, S.

AU - Sinico, R.A.

AU - Quartuccio, L.

AU - Lunardi, C.

AU - Parronchi, P.

AU - Moosig, F.

AU - Espigol-Frigole, G.

AU - Schroeder, J.

AU - Kernder, A.L.

AU - Monti, S.

AU - Silvagni, E.

AU - Crimi, C.

AU - Cinetto, F.

AU - Fraticelli, P.

AU - Roccatello, D.

AU - Vacca, A.

AU - Mohammad, A.J.

AU - Hellmich, B.

AU - Samson, M.

AU - Bargagli, E.

AU - Tervaert, J.W.C.

AU - Ribi, C.

AU - Fiori, D.

AU - Bello, F.

AU - Fagni, F.

AU - Moroni, L.

AU - Ramirez, G.A.

AU - Nasser, M.

AU - Marvisi, C.

AU - Toniati, P.

AU - Firinu, D.

AU - Padoan, R.

AU - Egan, A.

AU - Seeliger, B.

AU - European EGPA Study Group

AU - Emmi, Giacomo

PY - 2022/2

Y1 - 2022/2

KW - FOLLOW-UP

KW - PLACEBO

KW - EGPA

KW - SAFETY

U2 - 10.1002/art.41943

DO - 10.1002/art.41943

M3 - Article

C2 - 34347947

VL - 74

SP - 295

EP - 306

JO - Arthritis & Rheumatology

JF - Arthritis & Rheumatology

SN - 2326-5191

IS - 2

ER -